| 2011 |
ARHGAP18 (MacGAP) functions as a GTPase-activating protein for RhoA: overexpression suppresses RhoA activity and disrupts stress fiber formation, while siRNA knockdown enhances stress fibers, induces cell rounding, and causes sustained RhoA activation upon cell attachment. ARHGAP18 localizes to the leading edge during cell spreading and migration and is required for cell polarization. |
siRNA knockdown, overexpression, immunofluorescence, RhoA activity assays, cell spreading/migration assays |
Molecular biology of the cell |
High |
21865595
|
| 2013 |
The Drosophila ARHGAP18 orthologue Conundrum (Conu) interacts with Moesin (ERM protein), which recruits Conu to the cell cortex to negatively regulate RhoA activity. Cortically localized Conu promotes cell proliferation in a RhoGAP activity-dependent manner, and this growth-promoting function also appears dependent on increased Rac activity. |
Co-immunoprecipitation, genetic epistasis, cortical localization assays, RhoA activity assays, cell proliferation assays in Drosophila |
Molecular biology of the cell |
High |
23468526
|
| 2014 |
ARHGAP18 acts as a negative regulator of angiogenesis: loss of ARHGAP18 promotes endothelial cell hypersprouting in zebrafish and murine retinal vessel development. Endogenous ARHGAP18 acts specifically on RhoC (not other Rho isoforms) and relocalizes to angiogenic/destabilized EC junctions in a ROCK-dependent manner, suppressing tip cell behavior and stabilizing junctions at least partially through regulation of Dll4, Flk-1, and Flt-4. |
Zebrafish knockdown, murine retinal vessel analysis, siRNA in endothelial cells, ROCK inhibitor treatment, immunofluorescence localization, RhoC-specific activity assays |
Small GTPases |
High |
25425145
|
| 2010 |
SENEX (ARHGAP18) regulates stress-induced premature senescence (SIPS) in endothelial cells through the p16(INK4a)/retinoblastoma protein pathway; depletion by siRNA or high-dose H2O2 causes apoptosis, establishing SENEX as essential for EC survival. SENEX levels are regulated by H2O2-mediated stress but unchanged during replicative senescence. |
siRNA knockdown, H2O2-induced stress, SA-β-gal senescence assay, apoptosis assays, p16/Rb pathway analysis |
Blood |
Medium |
20664062
|
| 2017 |
ARHGAP18 localizes to microtubules in endothelial cells (confirmed by structured illumination, GSD, and TIRF microscopy and biochemical fractionation). Depletion of ARHGAP18 (siRNA or knockout mouse ECs) destabilizes microtubules (reduced acetylated α-tubulin and glu-tubulin), impairs endothelin-1 secretion, and reduces neutrophil transmigration; this destabilization is rescued by ROCK or HDAC6 inhibition but not by a GAP-mutant ARHGAP18. Thrombin enhances the plasma membrane-bound fraction of ARHGAP18. |
SIM, GSD, TIRF microscopy, biochemical fractionation, siRNA, ARHGAP18-knockout mouse ECs, ROCK/HDAC6 inhibitors, GAP-mutant rescue experiments |
Molecular biology of the cell |
High |
28251925
|
| 2017 |
miR-200b directly controls ARHGAP18 levels in triple-negative breast cancer cells; enforced miR-200b expression reduces ARHGAP18, activates RhoA, enhances focal adhesions/stress fibers, and reduces migration and metastasis. Enforced ARHGAP18 re-expression where miR-200b is stably expressed reduces RhoA activity and rescues migration. ROCK inhibition reverses miR-200b's anti-migratory effect. |
miR-200b stable expression, ARHGAP18 deletion/overexpression, RhoA activity assays, ROCK inhibitor, in vivo metastasis assays |
Cancer research |
High |
28619708
|
| 2017 |
ARHGAP18 depletion in mesenchymal stem cells increases basal RhoA activity and actin stress fiber formation, suppresses adipogenesis, and enhances osteogenic commitment. ARHGAP18 provides tonic RhoA inhibition in static conditions but is not required for mechanical strain-mediated RhoA activation (which depends on LARG GEF). |
siRNA knockdown, RhoA activity assays, Oil-Red-O staining, alkaline phosphatase staining, qPCR of lineage markers |
Bone |
Medium |
29208526
|
| 2017 |
ARHGAP18 protects against thoracic aortic aneurysm: Arhgap18-/- mice show a synthetic, proteolytic, and proinflammatory smooth muscle cell phenotype. ChIP studies revealed enrichment of H3K4me3 and depletion of H3K27me3 at MMP2 and TNF-α promoters in Arhgap18-deficient SMCs. TAA formation in Arhgap18-/- mice is associated with loss of Akt activation, and rapamycin (mTORC1 inhibitor) partially rescues the phenotype. |
Global Arhgap18 knockout mice, angiotensin II challenge, chromatin immunoprecipitation (ChIP), Western blotting for pAkt, rapamycin rescue |
Circulation research |
Medium |
28701309
|
| 2019 |
ARHGAP18 is required for endothelial cell alignment in the direction of laminar flow. Depletion of ARHGAP18 inhibits flow-induced alignment, disrupts junctions, activates NF-κB, and increases ICAM-1 while decreasing eNOS. ApoE-/-/Arhgap18-/- double-knockout mice on high-fat diet develop early atherosclerosis in normally atheroprotective regions. |
siRNA depletion, in vitro laminar flow, double-knockout mouse atherosclerosis model, NF-κB/ICAM-1/eNOS protein analysis |
Journal of the American Heart Association |
Medium |
30630384
|
| 2020 |
YAP is downstream of ARHGAP18 in endothelial cells: ARHGAP18 depletion decreases YAP expression yet causes its nuclear localization (activation), disrupts VE-Cadherin at junctions, and impairs flow-mediated alignment. ARHGAP18 overexpression upregulates YAP, promotes its phosphorylation, and decreases the YAP target Cyr61. YAP depletion itself also causes loss of alignment and NF-κB activation. |
siRNA knockdown, ARHGAP18 overexpression, confocal imaging of YAP nuclear localization, ARHGAP18-knockout mouse in vivo analysis, Cyr61/NF-κB target gene measurements |
Cell communication and signaling |
Medium |
32013974
|
| 2020 |
PKN3 phosphorylates ARHGAP18 in vitro; PKN3-ARHGAP18 interaction is mediated via the N-terminal part of ARHGAP18 and is enhanced by ARHGAP18 phosphorylation. Phosphorylation by PKN3 enhances ARHGAP18's GAP domain activity, contributing to negative regulation of active RhoA. |
Phosphoproteomic screen with analog-sensitive PKN3, in vitro kinase assay, Co-immunoprecipitation, GAP domain activity assay |
International journal of molecular sciences |
Medium |
33092266
|
| 2018 |
IP3R3 silencing decreases ARHGAP18 expression, reduces RhoA activity, decreases Cdc42 expression, and reduces FAK Y861 phosphorylation in breast cancer cells, placing ARHGAP18 in an IP3R3/ARHGAP18/RhoA/mDia1/FAK pathway that coordinates cytoskeletal remodeling and cell morphology. |
siRNA knockdown of IP3R3, Western blot, RhoA activity assay, immunofluorescence |
Biochimica et biophysica acta. Molecular cell research |
Medium |
29630900
|
| 2024 |
ARHGAP18 is localized by binding active (phosphorylated) microvillar ezrin, and this interaction enhances ARHGAP18's RhoGAP activity. Loss of ARHGAP18 disrupts the boundary between microvilli and the terminal web, causing aberrant assembly of myosin-2 filaments inside microvilli, indicating that the ezrin-ARHGAP18 module acts as a negative autoregulatory feedback to locally reduce RhoA activity in microvilli. |
Localization studies in epithelial cells, Co-IP of ARHGAP18 with active ezrin, GAP activity assays, ARHGAP18 loss-of-function with myosin-2 filament distribution readout |
eLife |
High |
38193818
|
| 2023 |
Transcription factor GATA1 binds the ARHGAP18 promoter and drives ARHGAP18 expression in hepatocellular carcinoma cells, as confirmed by luciferase reporter assay and ChIP-qPCR. GATA1 overexpression rescues the anti-proliferative effects of ARHGAP18 silencing. |
Luciferase reporter assay, ChIP-qPCR, GATA1 overexpression rescue, gain/loss-of-function assays |
Applied biochemistry and biotechnology |
Medium |
37171759
|
| 2021 |
ATG16L1 knockdown (impaired autophagy) causes accumulation of SQSTM1/p62 and ARHGAP18 protein, leading to decreased RhoA activity and reduced epithelial cell migration. Thiopurines mitigate this effect. ARHGAP18 protein accumulation in autophagy-impaired cells places ARHGAP18 as a substrate of the autophagic degradation machinery upstream of RhoA. |
ATG16L1/ATG5 siRNA knockdown, pharmacological autophagy inhibition, SQSTM1 knockdown, G-LISA RhoA activity, immunofluorescence, primary colonic tissue staining |
Disease models & mechanisms |
Medium |
33973626
|
| 2025 |
ARHGAP18 forms a complex with Hippo pathway components YAP and Merlin (NF2) in human epithelial cells. CRISPR/Cas9 knockout of ARHGAP18 causes cytoskeletal alterations (loss of basal actin bundles) driven by both dysregulated RhoA signaling and aberrant nuclear localization of YAP, indicating spatiotemporal coordination between Rho GTPase and Hippo signaling at the cytoskeleton. |
Co-immunoprecipitation (ARHGAP18 with YAP and Merlin), CRISPR/Cas9 knockout, super-resolution STORM microscopy, YAP nuclear localization assays |
Molecular biology of the cell |
High |
42126958
|
| 2025 |
ERK inhibits Ezrin activity in the cell body by phosphorylating the C-terminal tail of the Ezrin-activating kinase LOK, thereby releasing Ezrin's ability to recruit and activate ARHGAP18. This ERK-LOK-Ezrin-ARHGAP18-RhoA signaling axis controls RhoA activity and contractile stress fiber assembly for cell migration. |
Phosphorylation mapping, LOK kinase assay, Ezrin activity measurements, ARHGAP18 recruitment assay, stress fiber and RhoA activity readouts |
bioRxivpreprint |
Medium |
bio_10.1101_2025.11.15.688645
|